SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 84 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,510 | -99.9% | 2,833,364 | +34.7% | 0.00% | 0.0% |
Q3 2022 | $3,303,000 | +6.2% | 2,103,980 | +36.0% | 0.00% | 0.0% |
Q2 2022 | $3,110,000 | +20.9% | 1,547,181 | +51.0% | 0.00% | 0.0% |
Q1 2022 | $2,572,000 | -54.5% | 1,024,672 | +8.3% | 0.00% | -50.0% |
Q4 2021 | $5,657,000 | -37.1% | 945,943 | -13.2% | 0.00% | -33.3% |
Q3 2021 | $8,992,000 | -23.7% | 1,089,945 | -10.3% | 0.00% | -25.0% |
Q2 2021 | $11,780,000 | +29.2% | 1,215,747 | +10.3% | 0.00% | +33.3% |
Q1 2021 | $9,118,000 | +4.7% | 1,102,463 | -13.6% | 0.00% | 0.0% |
Q4 2020 | $8,710,000 | -35.7% | 1,276,134 | +5.0% | 0.00% | -40.0% |
Q3 2020 | $13,556,000 | +161.4% | 1,215,819 | +47.2% | 0.01% | +150.0% |
Q2 2020 | $5,185,000 | +448.7% | 825,730 | +60.8% | 0.00% | – |
Q1 2020 | $945,000 | -43.8% | 513,536 | +3.3% | 0.00% | -100.0% |
Q4 2019 | $1,681,000 | +44.9% | 497,324 | -8.3% | 0.00% | – |
Q3 2019 | $1,160,000 | -3.2% | 542,188 | +20.8% | 0.00% | – |
Q2 2019 | $1,198,000 | – | 448,740 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 2,186,520 | $38,526,000 | 10.61% |
Cormorant Asset Management, LP | 1,945,334 | $34,277,000 | 4.56% |
Aisling Capital LLC | 1,703,855 | $30,022,000 | 4.47% |
Wildcat Capital Management, LLC | 736,012 | $12,968,000 | 4.44% |
ACUTA CAPITAL PARTNERS, LLC | 212,402 | $3,743,000 | 2.31% |
Healthcare Value Capital, LLC | 50,000 | $881,000 | 0.92% |
EAM Investors, LLC | 249,028 | $4,388,000 | 0.51% |
TFS CAPITAL LLC | 150,812 | $2,657,000 | 0.26% |
GAGNON SECURITIES LLC | 11,001 | $194,000 | 0.08% |
Granite Investment Partners, LLC | 43,861 | $772,000 | 0.07% |